$BWXT

Why is BWX Technologies stock ticking down today?

BWX Technologies (BWXT) stock is down 0.7% in pre-market trading at $129.54 after reporting mixed Q3 results. Earnings beat estimates but revenue fell short. The company maintained full-year guidance, with revenue slightly below expectations. Shares have been under pressure, trading near 52-week lows.

Original reporting
Published Nov 3, 2026, 1:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BWXT
Bearish
high confidence
Mentioned
$BWXT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BWXTBearishHigh
01

Why it matters

The earnings miss may trigger short‑term selling pressure, though the expanding backlog and EBITDA margin improvement provide a longer‑term upside narrative.

02

Market read

First report of Q3 earnings; new data influences immediate trading decisions for BWXT.

03

What to watch

Free cash flow outlook nudged higher and EBITDA margins expanded, indicating operational strength.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

BWX Technologies reported Q3 results with an earnings beat but a revenue shortfall, leading to a modest pre‑market decline.

Company-level read

Ticker impact

$BWXTBearishHigh confidence
Context

Q3 earnings miss on revenue and in‑line guidance caused a 0.7% pre‑market decline.

Expected impact

likely pressure as the market prices in the revenue miss and modest guidance.

Evidence & confidence

Earnings beat was offset by a $17 M revenue shortfall and guidance that did not exceed consensus, triggering sell‑side sentiment.

Market effects

Defense and nuclear tech sector may see modest pullback as BWXT underperforms.

U.S. equities modestly affected; broader market mixed.

Limited to investors tracking U.S. defense contractors.

Counterpoint

Long‑term backlog of $8.56 B could support a rebound if investors focus on growth.

Key entities

  • BWX Technologies

    U.S. nuclear technology and defense contractor (ticker BWXT).

Related articles

$BWXTMedAI 8/10

BWXT Q3 2026 Earnings Call Transcript

BWXT reported Q3 2026 revenue of $953M, up 10% YoY, with Adjusted EBITDA at $180M and EPS at $1.26. Government Operations saw 22.6% EBITDA margin, while Commercial Operations grew 25%. The company secured contracts for nuclear projects, including the U.S. Army's Janus Program and a Canadian microreactor project. BWXT raised its 2026 free cash flow guidance to $350M-$360M and plans capacity expansions.

$BWXTMedAI 8/10

BWX Technologies Q3 Earnings Call Highlights

BWX Technologies reported Q3 highlights, including a $189M fuel contract and revenue growth in special materials. The company is advancing nuclear projects, such as a high-enriched uranium facility and a large-scale HPDU plant. BWXT also secured awards for its advanced nuclear reactors and raised its 2026 free-cash-flow outlook to $350M-$360M, maintaining adjusted EBITDA and EPS guidance.

$BWXTMed

BWX (NYSE:BWXT) misses Q3 2026 sales expectations

BWX reported Q3 2026 revenue of $953M, missing estimates by 2.1% but beating EPS expectations. Adjusted EBITDA and free cash flow margins improved. Management maintained full-year EPS guidance at $4.74 and raised EBITDA guidance. Backlog grew 15.6% year-on-year to $8.56B.